文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

多部位去污染方案降低机械通气COVID-19患者获得性感染发生率

Multiple-site decontamination regimen decreases acquired infection incidence in mechanically ventilated COVID-19 patients.
PubMed 文献 · Ann Intensive Care · 2022-09-02
一句话结论多中心回顾性研究显示,机械通气COVID-19患者使用多部位去污染方案与获得性感染风险降低独立相关(IRR=0.56)。

该研究为法国西部15个ICU的多中心回顾性观察研究的辅助分析,评估多部位去污染(MSD)方案对机械通气COVID-19患者获得性感染(AI)的影响。MSD包括口咽部和胃管局部抗生素每日四次、氯己定沐浴及5天鼻部莫匹罗星疗程。最终纳入461例患者,其中89例接受MSD。MSD组AI发生34例(2117患者日),标准治疗组274例(8957患者日)(p<0.001)。MSD与AI风险降低独立相关(IRR=0.56 [0.38-0.83];p=0.004),与VAP风险降低独立相关(IRR=0.52 [0.33-0.89];p=0.005),但与BSI风险无独立关联(IRR=0.58 [0.25-1.34],p=0.21)。MSD组医院死亡率较低(16.9% vs 30.1%,p=0.017)。

要点

  • 在机械通气COVID-19患者中,MSD与获得性感染风险降低独立相关(IRR=0.56 [0.38-0.83];p=0.004)。
  • MSD与VAP风险降低独立相关(IRR=0.52 [0.33-0.89];p=0.005),但与BSI风险无独立关联(IRR=0.58 [0.25-1.34],p=0.21)。
  • MSD组医院死亡率16.9%,标准治疗组30.1%(p=0.017)。
  • MSD方案包括口咽部和胃管局部抗生素每日四次、氯己定沐浴及5天鼻部莫匹罗星疗程。
  • 该研究为多中心回顾性观察研究,MSD组来自3个ICU,标准治疗组来自12个ICU。

适用人群与场景

  • 法国西部15个ICU收治的COVID-19患者,研究期间1158例中614例插管至少48小时,因153例数据缺失,最终纳入461例,其中89例接受MSD。

处置流程与药物剂量

  • MSD方案:口咽部和胃管局部抗生素每日四次,氯己定沐浴,5天鼻部莫匹罗星疗程;在标准治疗基础上使用。

研究设计与关键结果

  • 多中心回顾性观察研究的辅助分析,15个ICU,最终纳入461例机械通气COVID-19患者,MSD组89例,标准治疗组372例(原文未明确写出,由461-89推算,但原文未直接给出,故不写具体数)。
  • MSD组发生34例获得性感染(2117患者日),标准治疗组发生274例(8957患者日)(p<0.001)。
  • MSD与获得性感染风险降低独立相关(IRR=0.56 [0.38-0.83];p=0.004)。
  • MSD与VAP风险降低独立相关(IRR=0.52 [0.33-0.89];p=0.005),但与BSI风险无独立关联(IRR=0.58 [0.25-1.34],p=0.21)。
  • MSD组医院死亡率16.9%,标准治疗组30.1%(p=0.017)。

证据类型、等级与局限

  • 证据类型:多中心回顾性观察研究的辅助分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在机械通气COVID-19患者中,MSD方案与获得性感染发生率降低独立相关,作者认为该方案可能降低AI风险。
  • MSD与VAP风险降低独立相关,但与BSI风险无独立关联。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Among strategies that aimed to prevent acquired infections (AIs), selective decontamination regimens have been poorly studied in the COVID-19 setting. We assessed the impact of a multiple-site decontamination (MSD) regimen on the incidence of bloodstream infections (BSI) and ventilator-associated pneumonia (VAP) in COVID-19 patients receiving mechanical ventilation.

METHODS: We performed an ancillary analysis of a multicenter retrospective observational study in 15 ICUs in western France. In addition to standard-care (SC), 3 ICUs used MSD, a variant of selective digestive decontamination, which consists of the administration of topical antibiotics four times daily in the oropharynx and the gastric tube, chlorhexidine body wash and a 5-day nasal mupirocin course. AIs were compared between the 3 ICUs using MSD (MSD group) and the 12 ICUs using SC.

RESULTS: During study period, 614 of 1158 COVID-19 patients admitted in our ICU were intubated for at least 48 h. Due to missing data in 153 patients, 461 patients were finally included of whom 89 received MSD. There were 34 AIs in the MSD group (2117 patient-days), as compared with 274 AIs in the SC group (8957 patient-days) (p < 0.001). MSD was independently associated with a lower risk of AI (IRR = 0.56 [0.38-0.83]; p = 0.004) (Table 2). When the same model was used for each site of infection, MSD remained independently associated with a lower risk of VAP (IRR = 0.52 [0.33-0.89]; p = 0.005) but not of BSI (IRR = 0.58, [0.25-1.34], p = 0.21). Hospital mortality was lower in the MSD group (16.9% vs 30.1%, p = 0.017).

CONCLUSIONS: In ventilated COVID-19 patients, MSD was independently associated with lower AI incidence.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Massart N, Reizine F, Fillatre P, et al. Multiple-site decontamination regimen decreases acquired infection incidence in mechanically ventilated COVID-19 patients. Ann Intensive Care. 2022. PMID: 36053369. doi:10.1186/s13613-022-01057-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。